Cunningham Ann Michelle 4
4 · VistaGen Therapeutics, Inc. · Filed Apr 27, 2020
Insider Transaction Report
Form 4
Cunningham Ann Michelle
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-04-23+75,000→ 75,000 totalExercise: $0.40Exp: 2030-04-23→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total number of shares shall be vested immediately on April 23, 2020 (the "Vesting Start Date") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date.